Search
Now showing items 1-10 of 67
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial
DiNardo, Courtney D. et al. (2021)
Wissenschaftlicher Artikel
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group
Hoechstetter, Manuela A. et al. (2020)
Wissenschaftlicher Artikel
Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition
Greiner, Jochen et al. (2020)
Wissenschaftlicher Artikel
Analysis, identification and visualization of subgroups in genomics
Völkel, Gunnar et al. (2021)
Wissenschaftlicher Artikel
Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients
Greiner, Jochen et al. (2021)
Wissenschaftlicher Artikel
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial
Kapp-Schwoerer, Silke et al. (2020)
Wissenschaftlicher Artikel
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
Wei, Andrew H. et al. (2020)
Wissenschaftlicher Artikel
Deregulated expression of circular RNAs in acute myeloid leukemia
Lux, Susanne et al. (2021)
Wissenschaftlicher Artikel
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial
Cicconi, Laura et al. (2020)
Wissenschaftlicher Artikel
Measurable Residual Disease Response and Prognosis in Treatment-Naive Acute Myeloid Leukemia With Venetoclax and Azacitidine
Pratz, Keith W. et al. (2022)
Wissenschaftlicher Artikel